Published in Science on June 27, 2014
A physical zero-knowledge object-comparison system for nuclear warhead verification. Nat Commun (2016) 0.75
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med (2003) 11.17
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med (2002) 8.86
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med (2006) 8.16
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science (2011) 4.46
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood (2002) 3.60
Conservation ecology. Home, home outside the range? Science (2010) 2.83
Ecology. A world without corals? Science (2007) 2.83
DNA forensics. Buried, recovered, lost again? The Romanovs may never rest. Science (2004) 2.68
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood (2011) 2.66
Science in India. India rising. Science (2012) 2.39
Hydropower. Mayhem on the Mekong. Science (2011) 2.25
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors. Blood (2006) 2.18
History of science. Championing a 17th century underdog. Science (2003) 2.04
Environmental radioactivity. Radioecology's coming of age--or its last gasp? Science (2002) 2.03
Ecosystems. Have desert researchers discovered a hidden loop in the carbon cycle? Science (2008) 2.02
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant (2006) 1.99
Out in the cold. Science (2016) 1.97
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. PLoS Med (2008) 1.97
Bacteriophage therapy. Stalin's forgotten cure. Science (2002) 1.93
North Korea. Sizing up a slumbering giant. Science (2013) 1.93
China's environmental challenges. Three Gorges Dam: into the unknown. Science (2008) 1.82
Reimagining cities. Introduction. Science (2008) 1.77
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol (2011) 1.76
Ecology. Freshwater eels are slip-sliding away. Science (2003) 1.74
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol (2013) 1.68
North Korea. Visiting the hermit kingdom. Science (2004) 1.66
Climate change. China looks to balance its carbon books. Science (2011) 1.62
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412. Blood (2005) 1.58
Paleontology. Altering the past: China's faked fossils problem. Science (2010) 1.51
Biodiversity crisis on tropical islands. Last-gasp effort to save Borneo's tropical rainforests. Science (2007) 1.49
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. Drug Resist Updat (2009) 1.47
Solar physics. A space weather aerie in the Caucasus? Science (2003) 1.40
Ecological restoration. Seeking cures for North Korea's environmental ills. Science (2012) 1.40
Dam-building threatens Mekong fisheries. Science (2016) 1.39
Profile: Jin Huiqing. Car-crash epidemiologist pushes systemic attack on bad driving. Science (2011) 1.39
Gary Strobel profile: Biologist gets under the skin of plants--and peers. Science (2002) 1.39
Space science. Entangled secret messages from space. Science (2012) 1.39
Development and ecology. Villagers drafted into China's model of 'sustainability'. Science (2006) 1.39
Science for all. Science (2013) 1.39
Artificial intelligence. Rise of the Machines. Science (2015) 1.39
Engineering. A new great lake--or dead sea? Science (2008) 1.39
Public health. Despite gains, malnutrition among China's rural poor sparks concern. Science (2012) 1.39
Technical exchanges. U.S. visa delays on the rise, scientists abroad report. Science (2008) 1.38
Behavioral ecology. Ecologists roiled by misconduct case. Science (2004) 1.38
China. Daring experiment in higher education opens its doors. Science (2011) 1.38
Tainted milk scandal. Chinese probe unmasks high-tech adulteration with melamine. Science (2008) 1.38
Scientific exchanges. A wary pas de deux. Science (2004) 1.37
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells. Cancer (2007) 1.29
War in Iraq. U.N. inspections find wisps of smoke but no smoking guns. Science (2003) 1.29
Air pollution. Counting the cost of London's killer smog. Science (2002) 1.26
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther (2008) 1.23
Infectious disease. Racing to defuse a bacterial time bomb. Science (2007) 1.21
Food safety. Arsenic and paddy rice: a neglected cancer risk? Science (2008) 1.19
Seismology. A human trigger for the great quake of Sichuan? Science (2009) 1.16
Aquatic ecology. The last of the leviathans. Science (2007) 1.15
Battle for the Americas. Science (2013) 1.15
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. Blood (2007) 1.13
Epidemiology. Breaking the chain in Bangladesh. Science (2011) 1.13
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells. Blood (2008) 1.09
Science in Iran. The sturgeon's last stand. Science (2005) 1.08
Scientific exchanges. Nukes for windmills: quixotic or serious proposition? Science (2004) 1.07
Polar exploration. A year to remember at the ends of the Earth. Science (2004) 1.06
Plant science. China plans $3.5 billion GM crops initiative. Science (2008) 1.05
Materials science. As China's rare earth R&D becomes ever more rarefied, others tremble. Science (2009) 1.03
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells. Cancer Res (2007) 1.02
China's environmental challenges. Beijing's marathon run to clean foul air nears finish line. Science (2008) 1.02
Infectious diseases. Rival teams identify a virus behind deaths in central China. Science (2010) 1.02
Ecology. A threatened nature reserve breaks down Asian borders. Science (2006) 1.01
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells. Blood (2008) 1.01
Nursing China's ailing forests back to health. Science (2009) 1.00
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction. Blood (2008) 0.98
Diseases. A medical mystery in middle China. Science (2009) 0.97
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res (2013) 0.95
Biochemistry. Lifting the veil on traditional Chinese medicine. Science (2008) 0.95
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood (2011) 0.95
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Clin Cancer Res (2007) 0.95
2010 budget. China amasses war chest to confront its environmental nightmares. Science (2010) 0.94
Mycology. Last stand for the body snatcher of the Himalayas? Science (2008) 0.94
Public health. Is live smallpox lurking in the Arctic? Science (2002) 0.93
Marine biogeochemistry. The invisible hand behind a vast carbon reservoir. Science (2010) 0.93
The rise of restoration ecology. Science (2009) 0.93
MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells. Blood (2011) 0.93
Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist (2011) 0.92
Geophysics. Vigil at North Korea's Mount Doom. Science (2011) 0.92
Volcanology. Is China's riskiest volcano stirring or merely biding its time? Science (2010) 0.92
Communication in science pressures and predators. Scientific discourse: buckling at the seams. Introduction. Science (2013) 0.92
The FLT3 internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112. Cancer Res (2005) 0.92
Natural disasters. Ecologists report huge storm losses in China's forests. Science (2008) 0.90
Central Asia. Visions of a biotech empire on the Kazakh Steppe. Science (2005) 0.90
Devastation in Japan. Fukushima cleanup will be drawn out and costly. Science (2011) 0.90
Transboundary rivers. For China and Kazakhstan, no meeting of the minds on water. Science (2012) 0.89
Space exploration. One nuclear leap to Mars? Science (2003) 0.89
Ecology. Severe drought puts spotlight on Chinese dams. Science (2010) 0.89
Avian influenza. Combating the bird flu menace, down on the farm. Science (2006) 0.89
Ecology. Can palm oil plantations come clean? Science (2007) 0.89
China. Activists go on warpath against transgenic crops--and scientists. Science (2011) 0.89
Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells. PLoS One (2013) 0.88
Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28. J Immunother (2010) 0.88